A study to evaluate the effect of nolasiban on uterine contractions in women undergoing IVF or ICSI treatments
- Substances:Nolasiban
Spain- Participants:18–64 years
- Substances:Nolasiban
- Sponsor:ReproNovo ApS
Rare diseases
Investigational molecules
Locations
Back to Spain3 740 clinical trials in Esplugues De Llobregat, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)
SpainZanidatamab, tucatinib, capecitabine or eribulin mesylate in HER2-positive advanced breast cancer in adults
SpainLong-Term Study of Imeroprubart in Adults With Graves' Disease
SpainCenegermin Eye Drops for Persistent Corneal Epithelial Defect in Patients with Persistent Corneal Epithelial Defect
SpainDaridorexant for Insomnia in Patients with Major Depressive Disorder and Moderate to Severe Insomnia
SpainFWY003 in Geographic Atrophy Secondary to Age-Related Macular Degeneration in Patients
SpainLong-Term Safety Study of Zigakibart in Adults with IgA Nephropathy Who Have Completed Previous Zigakibart Trials
SpainBelzutifan and Zanzalintinib in Adults with Advanced Renal Cell Carcinoma After PD-1/L1 and VEGF-TKI Therapy
SpainMesalazine Monotherapy vs Continuing Thiopurines in Older Patients with Ulcerative Colitis in Long-Term Remission
SpainAZD0120 versus standard regimens in patients with relapsed or refractory multiple myeloma
SpainFrexalimab versus Tacrolimus for Prevention of Kidney Transplant Rejection in Adult Kidney Transplant Recipients
SpainA study to evaluate the efficacy and safety of rilzabrutinib in adults with active IgG4-related disease
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on pediatric cancers include studies for neuroblastoma, hepatic tumors, and various sarcomas. Research efforts target both primary and refractory disease states.
Studies are evaluating novel therapeutic approaches for improving patient outcomes in challenging pediatric cancers.
Research initiatives addressing rare genetic conditions are exploring new treatment options for conditions affecting children and young adults.
These trials aim to evaluate innovative therapies targeting specific genetic mechanisms.
Clinical research focusing on respiratory conditions and immunological responses, particularly in pediatric populations.
Studies emphasize both preventive measures and therapeutic interventions for respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.